OnKure Therapeutics, Inc. Class A OKUR
NASDAQ · United States · Health Technology
$2.54-0.19 (-6.79%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.31 | -0.54 | +42.1% | $0 | -100.0% | +3.5%$4.02→$4.16 |
| Q1 2026 | 2026-05-05 | -1.11 | -0.81 | -37.0% | — | — | -11.5%$4.60→$4.07 |
| Q4 2025 | 2026-03-12 | -0.99 | -1.15 | +13.9% | — | — | +7.1%$3.53→$3.78 |
| Q3 2025 | 2025-11-06 | -1.09 | -1.20 | +9.2% | — | — | -2.0%$3.00→$2.94 |
| Q4 2024 | 2025-03-10 | -1.37 | -0.87 | -57.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.